Skip to main content

ETF Objective

The Fund seeks to match as closely as possible the price and yield performance of the AMEX Gold Miners Index. The Fund, utilizing a "passive" or indexing investment approach, attempts to approximate the investment performance of the Index by investing in a portfolio of stocks that generally replicate the Index.

Stock Chart

as of 4:10 PM ET 11/29/2021

Performance

  • 1 Week
  • -2.64%
  • 1 Month
  • +1.32%
  • 3 Months
  • -1.47%
  • 1 Yr Return
  • n/a
  • 5 Yr Return
  • n/a

Sector Breakdown

Basic Materials 99.88%

Geographic Exposure

Canada 53.85%
United States 18.06%
Australia 13.34%
South Africa 7.19%
China 3.73%
United Kingdom 2.40%
Peru 0.76%
Jersey 0.56%

Top 10 Holdings

Symbol Company Name % Of Assets
NEM Newmont Corporation ORD 13.50%
ABX Barrick Gold Corp ORD 10.23%
FNV Franco-Nevada Corp ORD 8.54%
WPM Wheaton Precious Metals Corp ORD 5.69%
NCM Newcrest Mining Ltd ORD 5.26%
AEM Agnico Eagle Mines Ltd ORD 4.31%
KL Kirkland Lake Gold Ltd ORD 4.24%
GFI Gold Fields Ltd DR 3.12%
NST Northern Star Resources Ltd ORD 3.05%

ETF Overview

Sponsor Van Eck
iNav Ticker DWXT
Inception Date 05/16/2006
Name VanEck:Gold Miners
CUSIP 92189F106
Prospectus Date 05/01/2021

ETF Characteristics

Market Capitalization 17.59 B
Total Net Assets 13.37 K
Management Fee 0.50%
Administration Fee 0.00%
Asset Class Equity
Sub Asset Class Precious Metals Equity Funds
Number Of Holdings 55
Expense Ratio 0.51
Dividend n/a
Dividend Frequency Annually

LATEST NEWS

Recent Articles from TheStreet

pexels-alexander-suhorucov-6457488

Paycheck Advance: How to Help Your Employees

As a small business owner, you might be faced with an employee who requests a paycheck advance. Below are some common practices for providing a payroll advance.

Facebook Meta Logo Lead

Facebook Owner Meta told by U.K. Antitrust Regulator to Sell Giphy

Facebook parent Meta has been order by the U.K.’s competition watchdog to sell GIF-sharing platform Giphy, which it bought in 2020 for a reported $400 million.

Immunogen Tanks After Ovarian Cancer Drug Study Fails to Meet Endpoint

ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial

ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.

Semiconductor Lead

Lam Research and KLA: 2 Must-Own Chip-Equipment Stocks

Amid the chip shortage, two key equipment stocks fly under the radar: Lam Research and KLA.

Merck Lead

Merck Covid-19 Pill to Be Reviewed by FDA Advisory Panel

Merck’s Covid-19 oral antiviral pill will be reviewed by an outside panel of advisors to the FDA on Tuesday, paving the way for potential authorization by year-end.

Moderna vaccine Lead

Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings

Moderna said its Covid vaccine would likely experience a 'material drop' in efficacy against Omicron, while Regeneron warned its antibody cocktail may also have reduced activity against the new variant.

Wall Street Lead

Moderna Warns on Omicron, Powell, Yellen Face Senate - 5 Things You Must Know

Stocks slump as Omicron concerns resurface; Moderna CEO cautions on vaccine efficacy against new variant; Powell and Yellen to testify before the Senate Banking Committee on CARES Act; FTC orders supply chain probe and cloud adoption software group HashiCorp seeks $13 billion valuation in upcoming Nasdaq IPO.

Wall Street Lead

Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix

Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.

Lululemon Clothes Retail Lead

Lululemon Files Patent Lawsuit Against Peloton

Lululemon seeks injunction in leggings and sports bra design dispute with Peloton.